Celltrion
068270.KS
#659
Rank
โ‚น3.468 T
Marketcap
โ‚น15,136
Share price
3.61%
Change (1 day)
35.93%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): โ‚น299.71

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น303.79. In 2025 the company made an earnings per share (EPS) of โ‚น288.43 an increase over its 2024 EPS that were of โ‚น109.39.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น299.713.91%
2025โ‚น288.43163.66%
2024โ‚น109.39-53.73%
2023โ‚น236.44-2.08%
2022โ‚น241.46-11.72%
2021โ‚น273.512.03%
2020โ‚น268.0682.8%
2019โ‚น146.6418.31%
2018โ‚น123.94-36.33%
2017โ‚น194.68161.25%
2016โ‚น74.522.86%
2015โ‚น72.4517.84%
2014โ‚น61.485.87%
2013โ‚น58.07-70.85%
2012โ‚น199.21134.09%
2011โ‚น85.1043.59%
2010โ‚น59.2774.49%
2009โ‚น33.96317.8%
2008โ‚น8.13-71.7%
2007โ‚น28.73